CLNH 5
Latest Information Update: 28 Jul 2024
Price :
$50 *
At a glance
- Originator Nascent Biotech
- Class Anti-infectives; Antineoplastics; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Infections; Metabolic disorders
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for research development in Cancer in USA
- 28 Jul 2024 No recent reports of development identified for research development in Infections in USA
- 28 Jul 2024 No recent reports of development identified for research development in Metabolic-disorders in USA